Cargando…
A novel application of drug-eluting transarterial chemoembolization in treating non-liver cancers
This case series aimed to preliminarily evaluate the efficacy and safety of drug-eluting beads transarterial chemoembolization (DEB-TACE) in patients with lung, renal, gastric, and other non-liver cancers. Twenty-four patients who underwent DEB-TACE or DEB-TACE combined with other therapies were rev...
Autores principales: | Li, Zhen, Ji, Kun, Bai, Liangliang, Wang, Caihong, Hu, Yingying, Shi, Yang, Zhan, Pengchao, Song, Lijie, Li, Xin, Duan, Xuhua, Han, Xinwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402719/ https://www.ncbi.nlm.nih.gov/pubmed/32756080 http://dx.doi.org/10.1097/MD.0000000000020878 |
Ejemplares similares
-
Tumor Response and Nomogram-Based Prognostic Stratification for Hepatocellular Carcinoma After Drug-Eluting Beads Transarterial Chemoembolization
por: Ji, Kun, et al.
Publicado: (2022) -
Occurrence, Related Factors and Prognostic Value of Vascular Lake in Hepatocellular Carcinoma Patients Treated with Drug-Eluting Bead Transarterial Chemoembolization
por: Li, Hao, et al.
Publicado: (2021) -
The impact of drug-eluting bead (vs. conventional) transarterial chemoembolization on hepatic fibrosis in treating intermediate or advanced hepatocellular carcinoma
por: Li, Hao, et al.
Publicado: (2023) -
Comparison of Treatment Response, Survival Profiles, as Well as Safety Profiles Between CalliSpheres(®) Microsphere Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Huge Hepatocellular Carcinoma
por: Duan, Xuhua, et al.
Publicado: (2022) -
Exploring potential mechanisms of Suhexiang Pill against COVID-19 based on network pharmacology and molecular docking
por: Li, Jialin, et al.
Publicado: (2021)